Sign In
Buy COCP
$0.82
-0.0477 (-5.50%)
At Close: Jul 31, 2026
Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
08:00am, Wednesday, 29'th Nov 2023
BOTHELL, Wash., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), announces the presentation of favorable data demonstrating activity of i
Cocrystal Pharma to Present at the NobleCon 19 Conference on December 4, 2023
08:00am, Monday, 27'th Nov 2023
BOTHELL, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, Chief Financial Officer and Co-Chief Executi
Cocrystal Pharma to Discuss Progress with Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
08:00am, Thursday, 09'th Nov 2023
BOTHELL, Wash., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), announces that President and co-CEO Sam Lee, PhD will discuss progress i
BOTHELL, Wash., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces receipt of authorization from the United Kingdom Medicines and Healthcare P
Cocrystal Pharma to Participate in the H.C. Wainwright Global Investment Conference
08:00am, Tuesday, 05'th Sep 2023
BOTHELL, Wash., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing nove
Penny Stocks To Buy Now? 4 Under $3 To Watch This Week
10:28am, Monday, 10'th Apr 2023
Penny stocks to watch this week under $3. The post Penny Stocks To Buy Now?
Cocrystal Pharma to Participate in Two Investor Conferences in November
08:30am, Wednesday, 02'nd Nov 2022
BOTHELL, Wash., Nov. 02, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that management will participate in two upcoming investor conferences as follows: 2022 BioFlorida Ann
BOTHELL, Wash., Nov. 01, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces it has been granted European patent EP3866778 titled “Combinations Of Inhibitors of Influenza Virus
Cocrystal Pharma to Present at the LD Micro Main Event XV
08:30am, Wednesday, 19'th Oct 2022
BOTHELL, Wash., Oct. 19, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-interim CEO Sam Lee, PhD will present a company overview of their antiviral pro
Cocrystal Pharma to Present CC-42344 Phase 1 Influenza A Data at the World Antiviral Congress 2022
08:30am, Thursday, 13'th Oct 2022
BOTHELL, Wash., Oct. 13, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-interim CEO Sam Lee, PhD will present data from the Company’s Phase 1 influen
Cocrystal Pharma Selects CDI-988 for Clinical Development as an Oral Treatment for COVID-19
08:30am, Tuesday, 11'th Oct 2022
BOTHELL, Wash., Oct. 11, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the selection of its novel, broad-spectrum antiviral drug candidate CDI-988 for clinical development
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
08:30am, Wednesday, 05'th Oct 2022
BOTHELL, Wash., Oct. 05, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, CFO and interim co-CEO, will present a company overview at the Dawson James Securi
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
08:00am, Wednesday, 05'th Oct 2022
BOTHELL, Wash., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, CFO and interim co-CEO, will present a company overview at the Dawson James Securit
Cocrystal Pharma Announces a 1-for-12 Reverse Stock Split
04:30pm, Monday, 03'rd Oct 2022
BOTHELL, Wash., Oct. 03, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company) announces that its Board of Directors has approved a 1-for-12 reverse stock split of
Cocrystal Pharma to Present at the H.C. Wainwright Global Investment Conference
08:00am, Wednesday, 18'th May 2022
BOTHELL, Wash., May 18, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, Chief Financial Officer and co-interim Chief Executive Officer, will present a Compa
